1BALL P. Quinolone generations:natural history or natural selection[J] ? J Antimicrob Chemother , 2000, 46 (Suppl T1) : 17-24.
2Andersson MI, Macgowan AP. Development of the quinolones[J]. J Antimicrob Chemother, 2003, 51( Suppl i)t 1- 11.
3Aktas Z,Gonullu N,Salcloglu M, et al . Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin[J]. Int J Antimicrob Agents , 2002, 20 (3) : 196- 200.
4Rolston KV,Frisbee-HUMES, Leblane B, a al . Invitro anti- microbial activity of moxifloxacin compared to other quinolones against recent clinical bacterial Isolates form hospitalized and community-based cancer patients[J]. Diagn Microbiol Infect Dis ,2003, 47 (2):441-449.
5Chu DTW, Fernandes PB- Structure-activity relationships of the fluoroquinolones [J ]. Antimicrob Agents Chemother, 1989,33:131.
7Ping Wu, Laura E Lawrence, Kenneth L Denbleyker, et al. Mechanism of action of the Des-F (6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays[J]. Antirnicrob Agents Chemother , 2001,45 (14) : 3660.
10Ferrara M. New fluomquinolones in lower respiratory tract infections and emerging pattenrs of pneumoeoccal resistance [J]. Infection ,2005,33(3) :106-114.
10Emanuele Durante-Mangoni, Alexandros Grammatikos, Riccardo U- tili , Matthew E. Falagas. Do we still need the aminoglycosides[J] . Antimierobial Agents, 2009, 33:201-205.
